Literature DB >> 319139

Assessing bronchodilator responsiveness.

D G Tinkelman, S E Avner, D M Cooper.   

Abstract

This report concerns the difficulty in distinguishing variation due to drug effects from the spontaneous daily variation in baseline levels of pulmonary function in the evaluation of bronchodilator responsiveness in asthmatic children. Both prospective and retrospective studies were employed to assess the importance of the influence of the baseline level of function from which change is measured on the degree of responsiveness observed. It was found that for baseline levels up to approximately 90% of the predicted normal value, all patients had the capacity to respond significantly to a bronchodilator. However, there was no limit of baseline function below which a significant response did not occur.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 319139     DOI: 10.1016/0091-6749(77)90211-1

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  4 in total

1.  Prevalence of untreated asthma in a population sample of 6000 older adults in Bristol, UK.

Authors:  L Dow; L Fowler; L Phelps; K Waters; D Coggon; A L Kinmonth; S T Holgate
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

2.  Tachyphylaxis to beta-adrenoceptor agonists in human bronchial smooth muscle: studies in vitro.

Authors:  C Davis; M E Conolly
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

3.  Intravenous beta agonist in severe acute asthma.

Authors:  B Cheong; S R Reynolds; G Rajan; M J Ward
Journal:  BMJ       Date:  1988-08-13

Review 4.  Risks versus benefits of inhaled beta 2-agonists in the management of asthma.

Authors:  B J Lipworth
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.